Jan Lycke - Concepedia

Author

Jan Lycke

Also Known As

Annette Langer-Gould, Ching-Hua Lu, G Izquierdo Ayuso, J Lycke, J N Lycke, J. Lycke, Jan Lycke, Jan N. Lycke, Jan Nils Lycke, Lycke J

225

Publications

13.4K

Citations

H-Index

Concepts

All Affiliations

University of Gothenburg Sahlgrenska University Hospital Karolinska Institutet University College London Umeå University

About

Jan Lycke is an author at University of Gothenburg specializing in medicine, multiple sclerosis, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	33	3K
2	Allergy	4	4	169
3	Health Sciences	3	3	924
4	Public Health	1	1	401
5	Social Sciences	1	1	13

Jan Lycke

107

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
A multicentre validation study of the diagnostic value of plasma neurofilament light Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Nature Communications	2021	528
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies Gustavo Luna, Peter Alping, Joachim Burman, JAMA Neurology	2019	492
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein Lenka Novakova, Henrik Zetterberg, Peter Sundström, Neurology	2017	409
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Anna He, B. Merkel, J William L Brown, The Lancet Neurology Disease ProgressionNeurological DisorderClinical EpidemiologyClinical TrialsOutcomes Research	2020	401
Rituximab in multiple sclerosis Jonatan Salzer, Rasmus Svenningsson, Peter Alping, Neurology	2016	340
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab Martin Gunnarsson, Clas Malmeström, Markus Axelsson, Annals of Neurology	2010	337
Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis Jan Lycke, J.-E. Karlsson, Oluf Andersen, Journal of Neurology Neurosurgery & Psychiatry	1998	316
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS Clas Malmeström, Sara Haghighi, Lars Rosengren, Neurology	2003	315
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study Jens Kühle, Giulio Disanto, Ruth Dobson, Multiple Sclerosis Journal	2015	290

Page 1